Terms: = Kidney tumors AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA
25 results:
1. Downregulation of UBB potentiates SP1/VEGFA-dependent angiogenesis in clear cell renal cell carcinoma.
Wang J; Zhao E; Geng B; Zhang W; Li Z; Liu Q; Liu W; Zhang W; Hou W; Zhang N; Liu Z; You B; Wu P; Li X
Oncogene; 2024 May; 43(18):1386-1396. PubMed ID: 38467852
[TBL] [Abstract] [Full Text] [Related]
2. Alternative polyadenylation reprogramming of MORC2 induced by NUDT21 loss promotes KIRC carcinogenesis.
Tan Y; Zheng T; Su Z; Chen M; Chen S; Zhang R; Wang R; Li K; Na N
JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37737260
[TBL] [Abstract] [Full Text] [Related]
3. Gallstones, Cholecystectomy, and kidney Cancer: Observational and Mendelian Randomization Results Based on Large Cohorts.
Kharazmi E; Scherer D; Boekstegers F; Liang Q; Sundquist K; Sundquist J; Fallah M; Lorenzo Bermejo J
Gastroenterology; 2023 Jul; 165(1):218-227.e8. PubMed ID: 37054756
[TBL] [Abstract] [Full Text] [Related]
4. CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug.
Liang Y; Cen J; Huang Y; Fang Y; Wang Y; Shu G; Pan Y; Huang K; Dong J; Zhou M; Xu Y; Luo J; Liu M; Zhang J
Mol Cancer; 2022 Dec; 21(1):224. PubMed ID: 36536414
[TBL] [Abstract] [Full Text] [Related]
5. Transfection with Plasmid-Encoding lncRNA-SLERCC nanoparticle-mediated delivery suppressed tumor progression in renal cell carcinoma.
Mao W; Wang K; Zhang W; Chen S; Xie J; Zheng Z; Li X; Zhang N; Zhang Y; Zhang H; Peng B; Yao X; Che J; Zheng J; Chen M; Li W
J Exp Clin Cancer Res; 2022 Aug; 41(1):252. PubMed ID: 35986402
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathologic and molecular analysis of a
Hagoel TJ; Cortes Gomez E; Gupta A; Twist CJ; Kozielski R; Martin JC; Gao L; Kuechle J; Singh PK; Lynch M; Wei L; Liu S; Wang J; Ohm JE
Cold Spring Harb Mol Case Stud; 2022 Jan; 8(1):. PubMed ID: 34819304
[TBL] [Abstract] [Full Text] [Related]
7. Exposure to glyphosate and tetrachlorvinphos induces cytotoxicity and global DNA methylation in human cells.
Ergun H; Cayir A
Toxicol Ind Health; 2021 Oct; 37(10):610-618. PubMed ID: 34542374
[TBL] [Abstract] [Full Text] [Related]
8. Case report: Rare myeloid sarcoma development following renal transplantation with KRAS and dnmt3a gene mutations.
Wu D; Lu X; Yan X; Gao R
Diagn Pathol; 2021 Aug; 16(1):82. PubMed ID: 34465355
[TBL] [Abstract] [Full Text] [Related]
9. Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease.
Dawoud AAZ; Gilbert RD; Tapper WJ; Cross NCP
Leukemia; 2022 Feb; 36(2):507-515. PubMed ID: 34413458
[TBL] [Abstract] [Full Text] [Related]
10. Anti-neoplastic and demethylating activity of a newly synthetized flavanone-derived compound in Renal Cell Carcinoma cell lines.
Marques-Magalhães Â; Graça I; Miranda-Gonçalves V; Henrique R; Lopez M; Arimondo PB; Jerónimo C
Biomed Pharmacother; 2021 Sep; 141():111681. PubMed ID: 34139552
[TBL] [Abstract] [Full Text] [Related]
11. Clonal Cytopenia of Undetermined Significance in a Patient with Congenital Wilms' Tumor 1 and Acquired dnmt3a Gene Mutations.
Murakami K; Yamaguchi Y; Kida Y; Morikawa Y; Ujiie H; Sugahara H; Nannya Y; Ogawa S; Kanakura Y
Intern Med; 2021 Dec; 60(23):3785-3788. PubMed ID: 34053991
[TBL] [Abstract] [Full Text] [Related]
12. TET2 and dnmt3a mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models.
Yang SX; Hollingshead M; Rubinstein L; Nguyen D; Larenjeira ABA; Kinders RJ; Difilippantonio M; Doroshow JH
J Hematol Oncol; 2021 May; 14(1):83. PubMed ID: 34039392
[TBL] [Abstract] [Full Text] [Related]
13. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished
Kulkarni P; Dasgupta P; Bhat NS; Shahryari V; Shiina M; Hashimoto Y; Majid S; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
Mol Cancer Res; 2018 Nov; 16(11):1750-1760. PubMed ID: 30037856
[TBL] [Abstract] [Full Text] [Related]
14. An association between overexpression of DNA methyltransferase 3B4 and clear cell renal cell carcinoma.
Liu Y; Sun L; Fong P; Yang J; Zhang Z; Yin S; Jiang S; Liu X; Ju H; Huang L; Bai J; Gong K; Yan S; Zhang C; Shao G
Oncotarget; 2017 Mar; 8(12):19712-19722. PubMed ID: 28160561
[TBL] [Abstract] [Full Text] [Related]
15. Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells.
Mahalingaiah PK; Ponnusamy L; Singh KP
Oncotarget; 2017 Feb; 8(7):11127-11143. PubMed ID: 27655674
[TBL] [Abstract] [Full Text] [Related]
16. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensively understanding fatigue in patients with myeloproliferative neoplasms.
Scherber RM; Kosiorek HE; Senyak Z; Dueck AC; Clark MM; Boxer MA; Geyer HL; McCallister A; Cotter M; Van Husen B; Harrison CN; Mesa RA
Cancer; 2016 Feb; 122(3):477-85. PubMed ID: 26670597
[TBL] [Abstract] [Full Text] [Related]
18. Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma.
Li M; Wang Y; Song Y; Bu R; Yin B; Fei X; Guo Q; Wu B
Int J Clin Exp Pathol; 2014; 7(11):7597-609. PubMed ID: 25550796
[TBL] [Abstract] [Full Text] [Related]
19. Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A.
Szemes M; Dallosso AR; Melegh Z; Curry T; Li Y; Rivers C; Uney J; Mägdefrau AS; Schwiderski K; Park JH; Brown KW; Shandilya J; Roberts SG; Malik K
Hum Mol Genet; 2013 Jan; 22(1):74-83. PubMed ID: 23042785
[TBL] [Abstract] [Full Text] [Related]
20. Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasion.
Kokura K; Sun L; Bedford MT; Fang J
EMBO J; 2010 Nov; 29(21):3673-87. PubMed ID: 20871592
[TBL] [Abstract] [Full Text] [Related]
[Next]
